Pharmacokinetics of melphalan in myeloma patients undergoing an autograft.
C E
CE
Nath
P J
PJ
Shaw
J
J
Trotman
L
L
Zeng
D000970:Antineoplastic Agents / Q000627:therapeutic use; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D008558:Melphalan / Q000009:adverse effects / Q000493:pharmacokinetics*; D009101:Multiple Myeloma / Q000188:drug therapy / Q000628:therapy; D019653:Myeloablative Agonists / Q000009:adverse effects / Q000493:pharmacokinetics; D014182:Transplantation, Autologous
D000970:Antineoplastic Agents; D019653:Myeloablative Agonists; D008558:Melphalan